NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma
Ross J. Flockhart(Newcastle University), Penny E. Lovat(OJ-Bio (United Kingdom))
Cited by 71
Related Papers
Increasing Melanoma Cell Death Using Inhibitors of Protein Disulfide Isomerases to Abrogate Survival Responses to Endoplasmic Reticulum Stress
|Cancer Research|2008|174
Oncogenic B-RAF Signaling in Melanoma Impairs the Therapeutic Advantage of Autophagy Inhibition
|Clinical Cancer Research|2011|65
Inhibition of CXCR4–CXCL12 chemotaxis in melanoma by AMD11070
|British Journal of Cancer|2013|63
Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration*
|British Journal of Dermatology|2021|16